ANG Lifesciences India Limited (BOM:540694)

India · Delayed Price · Currency is INR

40.27

+0.78 (1.98%)

At close: Sep 25, 2026

Market Cap	525.86M +12.1%
Revenue (ttm)	835.87M -15.6%
Net Income	-133.23M
EPS	-10.22
Shares Out	13.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,666
Open	39.49
Previous Close	39.49
Day's Range	39.49 - 40.27
52-Week Range	17.63 - 49.69
Beta	0.65
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 23, 2026

About ANG Lifesciences India

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company also offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups... [Read more]

Industry Pharmaceutical Preparations

Founded 2006

Employees 379

Stock Exchange Bombay Stock Exchange

Ticker Symbol 540694

Full Company Profile

Financial Performance

In fiscal year 2026, ANG Lifesciences India's revenue was 928.93 million, an increase of 0.05% compared to the previous year's 928.47 million. Losses were -110.85 million, -10.70% less than in 2025.

Financial Statements